FDA inspection
Everest Life Sciences LLC: FDA inspection ending Apr 23, 2025
FDA inspection 1267697 · Voluntary Action Indicated (VAI) · Plainsboro, NJ
Key facts
| Inspection ID | 1267697 |
|---|---|
| Firm | Everest Life Sciences LLC |
| FEI number | 2243092 |
| Address | 31 Schalks Crossing Rd |
| City | Plainsboro |
| State | NJ |
| ZIP | 08536 |
| Country | United States |
| Fiscal year | 2025 |
| Inspection end date | Apr 23, 2025 |
| Classification | Voluntary Action Indicated (VAI) |
| Project area | Drug Quality Assurance |
| Product type | Drugs |
At a glance
- 1–9 Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 10–99 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data